NYSE:GKOS
Glaukos Corporation Stock News
$106.91
-1.07 (-0.99%)
At Close: May 08, 2024
Align Technology (ALGN) Q2 Earnings Lag Estimates, Margins Drop
11:14am, Thursday, 28'th Jul 2022 Zacks Investment Research
The dull underlying market situation, impacted by macro-economic environmental factors and lingering effects of COVID-19 variants in certain markets, impacts Align Technology's (ALGN) Q2 results.
Boston Scientific (BSX) Q2 Earnings Beat, Margins Decline
02:28pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem.
Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?
04:49pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.
IDEXX (IDXX) to Report Q2 Earnings: What's in the Cards?
04:46pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
IDEXX's (IDXX) Q2 performance will likely benefit from strong sales from the CAG Diagnostics and Water businesses.
Edwards Lifesciences (EW) to Post Q2 Earnings: What's in Store?
04:18pm, Monday, 25'th Jul 2022 Zacks Investment Research
Edwards Lifesciences' (EW) Q2 performance will likely reflect the continued adoption of the RESILIA tissue valves and enhanced sales of the HemoSphere platform.
Exact Sciences (EXAS) to Post Q2 Earnings: What's in Store?
04:11pm, Monday, 25'th Jul 2022 Zacks Investment Research
Exact Sciences' (EXAS) Q2 performance will likely reflect the benefit from continued adoption of the Oncotype DX breast test and robust Cologuard screening revenues.
Charles River (CRL) to Report Q2 Earnings: What's in Store?
03:33pm, Monday, 25'th Jul 2022 Zacks Investment Research
The broad-based demand and meaningful price increases in the RMS business, particularly in North America and China, are expected to have contributed to Charles River's (CRL) Q2 top line.
STERIS (STE) to Report Q1 Earnings: What's in the Cards?
02:29pm, Monday, 25'th Jul 2022 Zacks Investment Research
STERIS' (STE) Key Surgical and Cantel Medical businesses make significant contributions to consumable revenues within the Healthcare arm in Q1.
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
01:26pm, Monday, 25'th Jul 2022 Zacks Investment Research
Supply constraints, along with inflationary pressures, is likely to have weighed on DaVita's (DVA) second quarter's top line.
Intuitive Surgical (ISRG) Q2 Earnings Miss, Procedures Recover
12:53pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Intuitive Surgical's (ISRG) second-quarter results reflect health demand for procedures despite the resurgence of COVID-19 infections.
Here's Why Glaukos (GKOS) is a Great Momentum Stock to Buy
04:00pm, Thursday, 21'st Jul 2022 Zacks Investment Research
Does Glaukos (GKOS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is a Beat Likely for Intuitive Surgical (ISRG) in Q2 Earnings?
02:30pm, Monday, 18'th Jul 2022 Zacks Investment Research
Intuitive Surgical's (ISRG) second-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.
Here's Why You Should Add Glaukos (GKOS) to Your Portfolio
11:32am, Wednesday, 13'th Jul 2022
Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
Best Momentum Stocks to Buy for July 13th
11:32am, Wednesday, 13'th Jul 2022
JAZZ, GKOS and SPPI made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 13, 2022.
New Strong Buy Stocks for July 13th
08:29am, Wednesday, 13'th Jul 2022
KMI, UFCS, GKOS, SPPI and BECN have been added to the Zacks Rank #1 (Strong Buy) List on July 13, 2022.
